Local RAD50 gene delivery induces regression of preformed porcine coronary in-stent neointimal hyperplasia

Journal of Gene Medicine

Volumn 6, Issue 1, 2004, Pages 93-104

  Ahn, Young Keun ^a   Kook, Hyun ^a   Jeong, Myung Ho ^a   Ahn, Kyu Youn ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Kang, Jung Chaee ^a   Kim, Kyung Keun ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Endothelial cell; eNOS; Gene therapy; hRAD50; Restenosis; Stents

Indexed keywords

CASPASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LIPID; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PROTEIN P21; RAD50 PROTEIN; DNA BINDING PROTEIN; NITRIC OXIDE SYNTHASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAD50 PROTEIN, HUMAN;

ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTERY INTIMA; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; ENDOTHELIUM CELL; GENE TRANSFER; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN-STENT RESTENOSIS; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SWINE; VASCULAR PATENCY; ANIMAL; BIOSYNTHESIS; CULTURE TECHNIQUE; CYTOLOGY; FEMALE; GENE THERAPY; GENETICS; HYPERPLASIA; RESTENOSIS; SMOOTH MUSCLE; STENT;

SUIDAE; SUS SCROFA;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DEATH; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HYPERPLASIA; LIPIDS; MUSCLE, SMOOTH; NITRIC OXIDE SYNTHASE; PROTO-ONCOGENE PROTEINS P21(RAS); STENTS; SWINE;

EID: 4043062023     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.464     Document Type: Article

References (30)

1. Indolfi C, Coppola C, Torella D, et al. Gene therapy for restenosis after balloon angioplasty and stenting. Cardiol Rev 1999; 7: 324-331.
2. Casterella PJ, Teirstein PS. Prevention of coronary restenosis. Cardiol Rev 1999; 7: 219-231.
3. Schwartz RS. Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. Am J Cardiol 1998; 81: 14E-17E.
4. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
5. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495.
6. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a Sirolimus-eluting stent with standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
7. Guzman RJ, Hirschowitz EA, Brody SL, et al. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated vascular smooth muscle cell virus thymidine kinase gene. Proc Natl Acad Sci U S A 1994; 91: 10 732-10 736.
8. Chang MW, Barr E, Seltzer J, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 1995; 267: 518-522.
9. Chang MW, Barr E, Lu MM, et al. Adenovirus-mediated overexpression of the cyclin/cyclin-dependent kinase inhibitors, p21, inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 1995; 96: 2260-2268.
10. von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995; 92: 1137-1141.
11. Indolfi C, Avvedimento EV, Rapacciuolo A, et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med 1995; 1: 541-545.
12. Maillard L, Walsh K. Growth-arrest homeobox gene Gax: a molecular strategy to prevent arterial restenosis. Schweiz Med Wochenschr 1996; 126: 1721-1726.
13. Yonemitsu Y, Kaneda Y, Tanaka S, et al. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res 1998; 82: 147-156.
14. WAF1/CIP1-dependent manner: its potential utility in local gene therapy of tumor. Cell Growth Differ 2001; 12: 243-254.
15. Kim YC, Koh JT, Shin BA, et al. An anti-sense construct of full-length human RAD50 cDNA confers sensitivity to ionizing radiation and alkylating agents on human cell lines. Radiation Res 2002; 157: 19-25.
16. Kook H, Itoh H, Choi BS, et al. Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro. Am J Physiol Heart Circ Physiol 2003; 284 H1388-H1397.
17. Ahn YK, Jeong MH, Kim JW, et al. Preventive effects of the heparin-coated stent on restenosis in the porcine model. Cathet Cardiovasc Intervent 1999; 48: 324-330.
18. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19: 267-274.
19. Shears LL II, Kibbe MR, Murdock AD, et al. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J Am Coll Surg 1998; 187: 295-306.
20. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987; 84: 9265-9269.
21. Lamas S, Marsden PA, Li GK, et al. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A 1992; 89 6348-6352.
22. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992; 89: 10-18.
23. Varenne O, Pislaru S, Gillijns H, et al. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 1998; 98: 919-926.
24. Morris SM Jr, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994; 266: E829-E839.
25. Parenti A, Morbidelli L, Cui XL, et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 1998; 273: 4220-4226.
26. Morales-Ruiz M, Fulton D, Sowa G, et al. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cell is regulated via the serine/threonine kinase Akt. Circ Res 2000; 86: 892-896.
27. Lee PC, Kibbe MR, Schuchert MJ, et al. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells. Microvasc Res 2000; 60: 269-280.
28. Shen YH, Wang XL, Wilcken DE. Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett 1998; 433: 125-131.
29. DeYoung MB, Dichek DA. Gene therapy for restenosis. Are we ready? Circ Res 1998; 82: 306-313.
30. Mckay RG, Fram DB, Hirst JA, et al. Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: the Dispatch catheter. Cathet Cardiovasc Diagn 1994; 33: 181-188.